Top Institutions in Ophthalmology - Retinal Diseases
Leading institutions conduct large-scale clinical trials and translational research in retinal degenerative diseases, utilizing advanced imaging, visual function assessments, and molecular therapies to evaluate efficacy and safety of novel compounds like complement inhibitors.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a global leader in retinal disease research, with extensive experience in clinical trials for age-related macular degeneration and geographic atrophy, and strong translational research programs in complement inhibition therapies.
-
#2
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is consistently ranked as a top ophthalmology center with a robust retina division focused on AMD and GA, conducting innovative clinical trials and pioneering new therapeutic approaches including complement pathway modulation.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is renowned for its cutting-edge research in retinal diseases and has contributed significantly to understanding the pathophysiology of GA and testing novel interventions in clinical trials.
-
#4
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a strong retina division with a focus on AMD and GA, conducting early phase clinical trials and translational studies on novel therapeutics including complement inhibitors like ANX007.
-
#5
Moorfields Eye Hospital
London, N/A
Moorfields is a leading international center for retinal disease research and clinical trials, with a strong focus on AMD and GA, and has contributed to the development and evaluation of complement-targeting therapies.
